Targets of perturbagens

Perturbagen ID Perturbagen Reference Target Number Response ID
CID57221 2,4-bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine; Almitrina; Almitrinum DrugBank 1  NA
CID57222 Aprindina; Aprindine; Aprindinum; Compound 99170 DrugBank; CLUE; STITCH 4  NA
CID57223 Alizaprida; Alizapridum; Plitican DrugBank 1  NA
CID57224 (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefepima; Cefepime; Cefepime for injection; Cefepime for injection, usp; Cefepime hydrochloride; Cefepime hydrochloride and dextrose; Cefepimum; Maxipime; Maxipime for injection -pws iv im 1g; Maxipime for injection-pws iv 2gm DrugBank; STITCH 5  NA
CID57225 Isentress; Isentress hd DrugBank 1  NA
CID57226 6-chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide; 6-chloro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide; Chlorothiazid; Chlorothiazide; Chlorothiazide sodium; Chlorothiazidum; Chlorthiazide; Clorotiazida; Diuril; Mechlozid; Sodium diuril; Supres 150 tab; Supres 250 tab; Uroflux DrugBank; CLUE; STITCH 9  NA
CID57227 Eprosartan; (e)-2-butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid; (e)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1h-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; (e)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; Éprosartan; Eprosartan mesylate; Eprosartanum; Teveten; Teveten hct; Teveten plus DrugBank; CLUE; STITCH 8  RID73066 RID73230 RID73391
CID57228 Flupentixol; Flupenthixol; Flupenthixole; Flupentixol decanoate injection bp; Flupentixolo; Flupentixolum DrugBank; CLUE; STITCH 11  RID50801 RID51062 RID51324 RID51570 RID51831 RID63795 RID64055 RID64316 RID64568 RID64823 RID65070 RID65325 RID65575 RID65833 RID66091 RID66348 RID66606 RID66870
CID57229 Loteprednol; Alrex; Lotemax; Lotemax gel; Lotemax ointment; Loteprednolum CLUE; STITCH; DrugBank 1  RID56379 RID56617
CID57230 Dorzolamide; Dorzolamide hydrochloride; (4s-trans)-4-(ethylamino)-5,6-dihydro-6-methyl-4h-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide; (4s,6s)-4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide; (4s,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4h-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide; 4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide; 4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide; 4s,6s-dorzolamide; Apo-dorzolamide; Dorzolamid; Dorzolamida; Dorzolamide hcl; Dorzolamide hydrochloride ophthalmic solution; Dorzolamidum; Jamp-dorzolamide; Med-dorzolamide; Riva-dorzolamide; Sandoz dorzolamide; Trusopt DrugBank; CLUE; STITCH 11  RID44116 RID44117 RID44118 RID44119 RID44120 RID44121 RID44349 RID44350 RID44351 RID44352 RID44353 RID44354 RID44580 RID44581 RID44582 RID44583 RID44584 RID44585 RID03934